Teresa Carvalho, MS, science writer —

Seelos Therapeutics has been awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research to advance the development of its gene therapy candidate SLS-004 in people with Parkinson’s disease. SLS-004 aims to regulate the expression, or levels, of the SNCA gene, which provides instructions to produce…

The Massachusetts Institute of Technology (MIT) has developed a device that uses artificial intelligence (AI) to detect the presence and severity of Parkinson’s disease through patients’ breathing patterns. Because respiratory symptoms occur at early stages of the disease, researchers proposed that breathing assessment may help in diagnosing…

More people with Parkinson’s disease tend to require higher-level care after experiencing a hip fracture, compared to those who do not have the disease, a study has found. Despite Parkinson’s being a risk factor for hip fracture, most patients do not undergo proper screening or preventive treatment for osteoporosis.

The Parkinson’s Foundation announced it will invest $4.3 million in 29 grants for projects that will investigate the underlying causes of Parkinson’s disease and its biological mechanisms, with the goal of finding new treatments. This investment is in addition to the $10 million the Foundation committed to spend earlier this year. “The…